We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current HPHA market cap is 124.44M. The company's latest EPS is EUR and P/E is N/A.
| Year End 30 November 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 8.49M | 1.75M | 18.51M | 9.86M | 6.85M |
| Operating Income | -18.38M | -25.65M | -18.16M | -26.71M | -20.49M |
| Net Income | -18.37M | -26.14M | -19.7M | -20.35M | -19.38M |
| Year End 30 November 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 19.61M | 21.73M | 100.58M | 70.35M | 60.72M |
| Total Liabilities | 6.73M | 15.03M | 33.94M | 21.01M | 29.85M |
| Total Equity | 12.88M | 6.7M | 66.64M | 49.34M | 30.87M |
| Year End 30 November 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | -17.89M | -26.61M | -8.86M | -33.67M | -29.59M |
| Investing | -1.29M | -1.4M | -597k | 5.85M | -449k |
| Financing | 14.29M | 29.17M | 84M | -10.05M | 16.08M |
| Market Cap | 124.44M |
| Price to Earnings Ratio | N/A |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 46.6M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.13 (4.76%) |
| Company Name | Heidelberg Pharma AG |
| Address |
gregor-mendel-stra��e 22 ladenburg 68526 |
| Website | https://www.heidelberg-pharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
